Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0601BF08 GT1aa(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2238.18 C103H179N5O47
LMSP0601AT01 GT1b(d18:1/16:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2100.04 C93H161N5O47
LMSP0601BW01 GT1b(d18:1/16:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2116.03 C93H161N5O48
LMSP0601BW02 GT1b(d18:1/18:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2144.06 C95H165N5O48
LMSP0601AT02 GT1b(d18:1/18:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2128.07 C95H165N5O47
LMSP0601AT03 GT1b(d18:1/20:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2156.1 C97H169N5O47
LMSP0601BW03 GT1b(d18:1/20:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2172.09 C97H169N5O48
LMSP0601BW04 GT1b(d18:1/22:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2200.13 C99H173N5O48
LMSP0601AT04 GT1b(d18:1/22:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2184.13 C99H173N5O47
LMSP0601AT05 GT1b(d18:1/24:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2212.16 C101H177N5O47
LMSP0601BW05 GT1b(d18:1/24:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2228.16 C101H177N5O48
LMSP0601AT07 GT1b(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2210.15 C101H175N5O47
LMSP0601BW07 GT1b(d18:1/24:1(15Z)) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2226.14 C101H175N5O48
LMSP0601AT06 GT1b(d18:1/26:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2240.19 C103H181N5O47
LMSP0601BW06 GT1b(d18:1/26:0) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2256.19 C103H181N5O48
LMSP0601BW08 GT1b(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2254.17 C103H179N5O48
LMSP0601AT08 GT1b(d18:1/26:1(17Z)) NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2238.18 C103H179N5O47
LMSP0601CF01 GT1ba(d18:1/16:0) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2116.03 C93H161N5O48
LMSP0601CF02 GT1ba(d18:1/18:0) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2144.06 C95H165N5O48
LMSP0601CF03 GT1ba(d18:1/20:0) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2172.09 C97H169N5O48
LMSP0601CF04 GT1ba(d18:1/22:0) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2200.13 C99H173N5O48
LMSP0601CF05 GT1ba(d18:1/24:0) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2228.16 C101H177N5O48
LMSP0601CF07 GT1ba(d18:1/24:1(15Z)) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2226.14 C101H175N5O48
LMSP0601CF06 GT1ba(d18:1/26:0) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2256.19 C103H181N5O48
LMSP0601CF08 GT1ba(d18:1/26:1(17Z)) Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2254.17 C103H179N5O48
LMSP0601AR01 GT1c(d18:1/16:0) Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2100.04 C93H161N5O47
LMSP0601AR02 GT1c(d18:1/18:0) Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2128.07 C95H165N5O47
LMSP0601AR03 GT1c(d18:1/20:0) Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2156.1 C97H169N5O47
LMSP0601AR04 GT1c(d18:1/22:0) Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2184.13 C99H173N5O47
LMSP0601AR05 GT1c(d18:1/24:0) Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2212.16 C101H177N5O47
LMSP0601AR07 GT1c(d18:1/24:1(15Z)) Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2210.15 C101H175N5O47
LMSP0601AR06 GT1c(d18:1/26:0) Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2240.19 C103H181N5O47
LMSP0601AR08 GT1c(d18:1/26:1(17Z)) Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2238.18 C103H179N5O47
LMSP0601AO01 GT2(d18:1/16:0) GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1937.98 C87H151N5O42
LMSP0601AO02 GT2(d18:1/18:0) GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1966.01 C89H155N5O42
LMSP0601AO03 GT2(d18:1/20:0) GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1994.05 C91H159N5O42
LMSP0601AO04 GT2(d18:1/22:0) GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2022.08 C93H163N5O42
LMSP0601AO05 GT2(d18:1/24:0) GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2050.11 C95H167N5O42
LMSP0601AO07 GT2(d18:1/24:1(15Z)) GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2048.09 C95H165N5O42
LMSP0601AO06 GT2(d18:1/26:0) GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2078.14 C97H171N5O42
LMSP0601AO08 GT2(d18:1/26:1(17Z)) GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 2076.12 C97H169N5O42
LMSP0601AL01 GT3(d18:1/16:0) NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1734.9 C79H138N4O37
LMSP0601AL02 GT3(d18:1/18:0) NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1762.94 C81H142N4O37
LMSP0601AL03 GT3(d18:1/20:0) NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1790.97 C83H146N4O37
LMSP0601AL04 GT3(d18:1/22:0) NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1819 C85H150N4O37
LMSP0601AL05 GT3(d18:1/24:0) NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1847.03 C87H154N4O37
LMSP0601AL07 GT3(d18:1/24:1(15Z)) NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1845.01 C87H152N4O37
LMSP0601AL06 GT3(d18:1/26:0) NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1875.06 C89H158N4O37
LMSP0601AL08 GT3(d18:1/26:1(17Z)) NeuAcalpha2-8NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1873.04 C89H156N4O37
LMSP0601BH01 Gal-GD1b(d18:1/16:0) Galalpha1-3Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Acidic glycosphingolipids [SP06] Gangliosides [SP0601] 1970.99 C88H154N4O44